Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 101,106

Document Document Title
WO/2018/034226A1
Provided is an anti-PD-1 antibody that can be administered frequently even to animals other than rats. An anti-PD-1 antibody including: (a) an L chain that has an L chain variable region including CDR1 having the amino acid sequence of Q...  
WO/2018/034097A1
Provided is a cell encapsulation method capable of encapsulating, by an easy operation and under mild conditions, a cell in a capsule (polymer layer) having superior stability and permeability and low toxicity. This method for encapsulat...  
WO/2018/034538A1
The present invention relates to an Escherichia coli Ajou_CEM45W strain (KCTC 12986BP). According to the present invention, it was confirmed that the Ajou_CEM45W (KCTC 12986BP) strain is nondependent on a carbon source or culture tempera...  
WO/2018/032798A1
Provided are a Trichoderma reesei mutant strain and applications thereof. Compared with the starting strain, the Trichoderma reesei mutant strain significantly increases the yield of a non-starch polysaccharase and is broadly applicable ...  
WO/2018/035411A1
Phosphoethanolamine cellulose and methods of making and using it are disclosed. In particular, the invention relates to a method of producing a phosphoethanolamine cellulose biosynthetically using a BcsG phosphoethanolamine transferase f...  
WO/2018/034565A1
The invention is directed to a method for using a gaseous feed stream comprising CO2 as a feed stream for growing algae, said method comprising a) contacting said gaseous feed stream with an absorption liquid comprising carbonic anhydras...  
WO/2018/034298A1
The present invention provides a genetically-modified Trypanosoma cruzi having a calcium indicator, and an application of said Trypanosoma cruzi for screening of an anti-trypanosome agent. More specifically, the present invention provide...  
WO/2018/034203A1
This lactic acid bacteria is a lactic acid bacteria that belongs to the genus Leuconostoc and that has the accession number NITE BP-02307, a lactic acid bacteria that belongs to the genus Leuconostoc and that has the accession number NIT...  
WO/2018/034204A1
[Problem] To provide: a method for producing a seasoning agent capable of imparting a unique flavor to food; and effective use of a yeast residue. [Solution] This seasoning agent, which is obtained by adding a yeast residue as an excipie...  
WO/2018/032797A1
Provided are an Aspergillus niger mutant strain and applications thereof. The Aspergillus niger mutant strain is applicable in the production of non-starch polysaccharase. Compared with the starting strain, the mutant strain significantl...  
WO/2018/034135A1
[Problem] To develop: a method for manufacturing useful mature compost in a short time; and functional compost. [Solution] A method for manufacturing compost in which bacteria-carrying sewage sludge residue pellets, in which bacillus bac...  
WO/2018/033146A1
A system for preparing a biomass monomer by means of microbial coculture. With biomass as a substrate, by means of process regulation and control by a special device, coculture of biomass degrading microbes and target product microbes is...  
WO/2018/032240A1
Provided herein is a genetically modified host cell comprising a heterologous nucleic acid encoding a biofilm dispersal polypeptide that decreases intracellular c-di-GMP levels and enhances the production of lysine and lysine derivatives...  
WO/2018/028553A1
A stripe disease resistant gene Stv-bi of rice plants and an application thereof. The amino acid sequence of Stv-bi is shown as SEQ ID NO: 4 or SEQ ID NO: 7 in the sequence listing. The Stv-bi protein regulates a biological function of t...  
WO/2018/030405A1
An anti-HMGB1 antibody which holds a light chain variable region including complementarity determining regions respectively comprising the amino acid sequences represented by SEQ ID NOS: 4-6, etc. and a heavy chain variable region includ...  
WO/2018/031531A4
Engineered bacteria that express a protein having a nonstandard amino acid, pharmaceutical compositions comprising the bacteria, biofilms comprising a protein having a nonstandard amino acid, and methods for using the bacteria for diagno...  
WO/2018/028100A1
A Lactococcus lactis strain and use thereof, belonging to the field of food biotechnology. A separated strain is named as Lactococcus lactis WH101. The OD600 value at pH 4.5 reaches 0.527 and increases, as compared to that before mutagen...  
WO/2018/028006A1
Provided are a mycobacterium neoaurum, a ketosteroid C27-monooxygenase derived from mycobacterium neoaurum, and application of the ketosteroid C27-monooxygenase. By adding expressions of SMO isoenzyme SMO1, SMO2 and/or SMO3 to mycobacter...  
WO/2018/031531A1
Engineered bacteria that express a protein having a nonstandard amino acid, pharmaceutical compositions comprising the bacteria, biofilms comprising a protein having a nonstandard amino acid, and methods for using the bacteria for diagno...  
WO/2018/030526A1
Provide are a transformant of S.pombe enabling production of 3-HP with a high productivity without requiring neutralization with an alkali, and a method for producing 3-HP by culturing said transformant. The transformant uses Schizosac...  
WO/2018/029353A1
The present invention relates to a process for producing single cell protein, wherein a thermophilic fungus is grown a fermentable carbon-rich feedstock at a high temperature and at an acidic pH. This allows for a cost effective fermenta...  
WO/2018/030837A1
The present invention relates to: a novel Lactobacillus acidophilus YT1 strain (deposit number: KCCM11808P); and a composition for preventing, alleviating, or treating menopause, containing, as an active ingredient, Lactobacillus acidoph...  
WO/2018/030838A1
The present invention relates to a novel Lactobacillus intestinalis YT2 strain (accession No: KCCM11812P) and a composition comprising Lactobacillus intestinalis inclusive of the novel strain as an effective ingredient for prevention, al...  
WO/2018/030536A1
A genome editing method that uses a single-stranded polynucleotide that comprises: (i) a modified base sequence that results from (ia) deletion of an arbitrary base sequence from an arbitrary sense strand base sequence of genomic DNA, (i...  
WO/2018/030507A1
The present invention provides a production method for an L-amino acid such as L-lysine. An L-amino acid is produced by culturing, in a culture medium, bacteria having L-amino acid producing ability, bacteria that have been modified to h...  
WO/2018/030730A1
The present invention relates to an animal feed additive composition comprising a novel Lactobacillus salivarius CJLS1511 strain or dead cells thereof, and to a method for producing the dead cells.  
WO/2018/027276A1
The present invention relates to fungi, plants infected with fungi, products produced by fungi, and related methods. More particularly, the present invention relates to a method for selecting and/or characterising a fungus, which include...  
WO/2018/031286A1
The present invention relates to the discovery that the sugar analogs improve survival of subjects with disease.  
WO/2018/027898A1
Provided are Faecalibacterium butyricigenerans and a method for cultivation thereof and an application thereof; the classification name of said faecalibacterium is Faecalibacterium butyricigenerans, the name of the strain is AF52-21, and...  
WO/2018/025997A1
Provided are: a hemicellulase capable of degrading maize NSPs; DNA encoding the same; and use thereof. Provided by the present invention are proteins that have hemicellulase activity, such as Xyn5A, Xyn10B, Xyn11A, Xyn30A, and Xyn43A.  
WO/2018/025204A1
The present invention relates to selected bacterial strains belonging to the genus Lactobacillus and the use thereof for the treatment of bacterial biofilms and, specifically, for preventive treatment aimed at inhibiting and/or reducing ...  
WO/2018/026446A1
Composition comprising bacterial spore and its non-germinant (preferably amino acid, more preferably valine or aspargine) which alone in water does not cause germination of said spore, but accelerate its germination in combination with k...  
WO/2018/026762A1
Provided herein are highly sensitive compositions and methods for detection of at least one specific nucleic acid molecule in a sample. The presence of a specific nucleic acid provides a positive indicator of a pathogenic agent, contamin...  
WO/2018/027181A1
The invention pertains to a method for synthesizing a product of interest by culturing a microbe that produces the product of interest, the method comprising culturing the microbe in a culture medium, wherein the culture medium is produc...  
WO/2018/025886A1
The present invention relates to a method for producing a recombinant protein using a recombinant cell capable of expressing the recombinant protein under the regulation of an inducible promoter, said method comprising culturing the reco...  
WO/2018/025929A1
Provided are a mutant strain of a filamentous fungus having enhanced protein secretion production, and a protein production method using the filamentous fungus. Specifically provided is a protein production method that includes a step ...  
WO/2018/027167A1
Described herein are systems and methods of fixing inorganic carbon using an amount of Clostridium beijerinckii.  
WO/2018/026719A1
The invention provides a method and bacterial compositions for reducing or preventing an infection of a bodily tissue by a fungal microorganism by contacting the tissue with a composition comprising a purified Lactobacillus paracasei bac...  
WO/2018/026729A1
A method of immunizing a susceptible host against a pathogen comprising administering to the host a vaccine that comprises an attenuated recombinant live vaccine strain lacking a polynucleotide encoding CapB (LVS AcapB), wherein the LVS ...  
WO/2018/023151A1
The present invention relates to a biologically pure culture comprising an isolated Duddingtonia flagrans (D. flagrans) strain IAH 1297 deposited at the National Measurement Institute, 1/153 Bertie Street, Port Melbourne, Victoria 3207, ...  
WO/2018/021797A1
The present invention relates to Bacillus methylotrophicus strain DR-08, which produces a natural volatile compound and has antibacterial activity, and a use thereof. The Bacillus methylotrophicus strain DR-08 according to the present in...  
WO/2018/021363A1
The present invention provides a cell cultivation device that is characterized by comprising: a polymer porous film; a cell cultivation part that has the polymer porous film; a shaft that passes through the cell cultivation part; and a c...  
WO/2018/019245A1
Provided is a method of producing at least one omega-hydroxyl fatty acid, the method comprising: (a) contacting at least one alkane with at least one recombinant yeast cell in an aqueous medium, wherein the yeast cell is capable of oxidi...  
WO/2018/022974A1
Provided herein are engineered Salmonella enterica serovar Typhimurium strains and compositions, including vaccines, thereof. Also provided herein are methods of treating and/or preventing infection by at least Salmonella enterica serova...  
WO/2018/018111A1
The present invention relates to industrial yeast LVY127 genetically modified via the oxy-reductive xylose conversion pathway, to genetic expression cartridges, to a method for obtaining ethanol 2G and to the use of the yeast LVY127.  
WO/2018/018569A1
Provided is a method for increasing production of an L-arginine by knocking-out a flavoprotein reductase. A Corynebacterium crenatum SDNN403 genome is used as a template. Overlap extension PCR is used to acquire a missing gene fragment o...  
WO/2018/019656A1
The present invention provides a modified strain of the bacterium Lactococcus lactis obtainable by a method that comprises a step of fusion of two protoplasts from two Lactococcus lactis parental strains which, compared to the wild type ...  
WO/2018/021324A1
The purpose of the present invention is to provide a polypeptide having lipase activity with improved stability (heat, pH, solvent). The polypeptide at least includes, from the N-terminal side, β sheet (A), α helix (A), α helix (B), ...  
WO/2018/021046A1
Provided is a transformant that produces a PHA copolymer containing a 3HH unit at a higher composition ratio, and a method for producing a copolymerized PHA using the transformant. The transformant that produces a PHA copolymer containin...  
WO/2018/022327A1
One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimic...  

Matches 251 - 300 out of 101,106